Navigation Links
Elsevier launches Bioscience Hypotheses
Date:6/9/2008

London, UK, 9 June 2008 Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce the publication of Bioscience Hypotheses (http://www.sciencedirect.com/science/journal/17562392), a new journal for radical hypotheses on topics throughout the life sciences.

The aim of the journal is to stimulate innovation by choosing work that is interesting and challenging, and provides a clear and coherent argument with a testable conclusion. Bioscience Hypotheses is edited by Dr William Bains, biotechnology entrepreneur and innovator, and visiting lecturer at the University of Cambridge.

The journal welcomes papers that:

  • deliver new insight into the understanding or application of biology that could be of interest to a wide life science readership

  • are clear, coherent, and lay out an argument that is easy to follow

  • are not incompatible with known fact (although they may contest the interpretation of those facts)

  • provide an interpretation, hypothesis or solution that is testable.

Papers that do not provide a means of testing their conclusion, or differentiating their conclusion from other explanations, will be rejected. Papers that provide some preliminary data (itself perhaps not sufficiently robust to be published as an independent paper, but nevertheless rigorously collected) will be welcomed. However, preliminary data are not a requirement for publication, and Bioscience Hypotheses is not a forum for new experimental results unless they are supporting a broader theoretical structure.

Papers are not subject to standard peer review, but are selected by the Editor on the basis of the criteria laid out above. The journal explicitly does not publish papers addressing medical issues, which should continue to be directed to the sister journal Medical Hypotheses.


'/>"/>

Contact: Samantha Savalio
s.savalio@elsevier.com
44-207-424-4392
Elsevier
Source:Eurekalert

Related biology news :

1. Institution of Chemical Engineers chooses Elsevier as publishing partner
2. Elsevier announces new journal partnership for 2008
3. Elsevier launches new journal: Journal of Natural Gas Science and Engineering
4. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
5. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
6. $22 million gift from Alfred Taubman launches new biomedical research institute
7. BioMed Central launches Biology Image Library
8. Arizona State University launches biofuel initiative with BP and Science Foundation Arizona
9. UW launches cutting-edge DNA fin-printing project for salmon
10. SLIM Search Launches Academic Pricing Program
11. EMD Serono launches easypod, new electronic growth hormone injection device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
(Date:6/9/2016)... Paris Police Prefecture and ... ensure the safety of people and operations in several locations ... Teleste, an international technology group specialised in broadband ... its video security solution will be utilised by ... across the country. The system roll-out is scheduled for the ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 02, 2016 , ... In anticipation ... and lumbar disc production, company President, Jake Lubinski will be traveling to Switzerland ... AxioMed disc in Bern, Lucerne, and Zurich to discuss the benefits of a ...
(Date:12/2/2016)... OAKS, Calif. , Dec. 2, 2016 Amgen ... AGN ) today announced the submission of a Marketing ... ABP 215, a biosimilar candidate to Avastin ® (bevacizumab). ... application submitted to the EMA. "The submission ... as Amgen seeks to expand our oncology portfolio," said ...
(Date:12/2/2016)... , ... December 01, 2016 , ... ACEA Biosciences, Inc. ... Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer 2016, ... an update on the phase I/II clinical trials for AC0010 in patients with advanced ...
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ... Computational Science Symposium (CSS) and the popularity of US Single Day Events (SDE) ... place in early Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and ...
Breaking Biology Technology: